CrowdStrike vs. Figma: Which Technology Stock Is a Better Buy in 2026?

The article favors CrowdStrike for 2026, citing record net new ARR growth of more than 50% year over year, record free cash flow and a substantial increase to its full-year outlook. For FY2026, CrowdStrike reported revenue of nearly $4.8B (+21.7%) and a $162.5M net loss; Figma reported FY2025 revenue of nearly $1.1B (+41%) and a $1.3B net loss. Figma is cheaper on the cited multiples (75.6x forward P/E and 8.2x sales versus CrowdStrike’s 211.9x and 50.1x), but the article highlights ongoing competition, operational and AI-pricing risks for both companies.

Analysis

The key distinction is cash-flow quality, not headline growth. CRWD’s security demand has a durable structural tailwind as AI expands enterprise attack surfaces, but the post-incident discounting used to protect renewals could dilute the value of new ARR if it becomes persistent. Its premium leaves little room for a weaker renewal cycle or evidence that cash generation depends heavily on stock-based compensation (SBC). Verify retention, net-new ARR quality, and SBC-adjusted cash conversion rather than relying on management’s characterization of the quarter.

FIG’s lower sales multiple may offer better relative value, but it is not automatically cheap: seat-based pricing could be cannibalized by AI-assisted workflows, while usage pricing shifts revenue toward less predictable consumption and may add compute costs. Its reported cash generation also appears especially sensitive to SBC. The stated forward P/E comparison is not a clean anchor when current earnings are negative; confirm the forecast basis and dilution assumptions before using it.

Over 1–3 months, renewal indicators and guidance quality are the catalysts for CRWD; paid AI adoption, seat expansion, and monetization are the proof points for FIG. Over 6–18 months, security demand is the more legible structural theme, while FIG’s outcome depends on whether AI increases paid usage rather than reducing design seats. Shared AWS dependence creates an operational tail risk for both, not a differentiated thesis. The contrarian angle: FIG’s valuation discount could narrow if AI monetization is demonstrated, but today that is a catalyst to verify, not a reason to assume convergence.

Key Decisions for Investors

• Prefer CRWD for quality of demand, but avoid chasing at a premium valuation; consider staged entry on weakness, contingent on renewals holding without persistent discounting. Falsify if net-new ARR or retention materially deteriorates, or SBC-adjusted cash conversion weakens.
• Keep FIG on a catalyst watch rather than treating its lower sales multiple as a buy signal. Reassess after evidence that paid AI usage and seat expansion offset any seat cannibalization; monitor dilution and SBC-adjusted cash flow.
• If expressing a relative view, use a small, risk-controlled long FIG/short CRWD pair only after FIG demonstrates paid AI monetization. The thesis is valuation-gap compression, not superior business quality; exit if FIG’s paid adoption stalls or CRWD’s renewal/ARR metrics remain resilient enough to justify its premium.